Wellik Sarah R

Song Luo, Shen Lucy Q, Pasquale Louis R, Boland Michael V, Wellik Sarah R, De Moraes Carlos Gustavo et al.

Dual-level VF patterns (trunk-branch) predict glaucoma progression and polygenic risk scores better than single-level patterns. This offers refined disease classification, improving tailored patient management and understanding genetic underpinnings.

Lokhande Anagha, Song Luo, Pang Yueyin, Luo Yan, Pasquale Louis R, Wellik Sarah R et al.

This study found worse myopia correlates with worse paracentral visual field loss and faster glaucoma progression, even in mild cases, highlighting myopia as a significant risk factor.

Shi Min, Lokhande Anagha, Tian Yu, Luo Yan, Eslami Mohammad, Kazeminasab Saber et al.

A deep learning model accurately predicted 10-2 visual fields from 24-2 data, enhancing the structure-function relationship in glaucoma. This could improve glaucoma diagnosis.

Saeedi Osamah, Boland Michael V, D'Acunto Loris, Swamy Ramya, Hegde Vikram, Gupta Surabhi et al.

Machine learning algorithms effectively detect glaucoma progression with accuracy comparable to conventional methods, but are more balanced, potentially aiding clinical decision-making.

Teng Bettina, Li Dian, Choi Eun Young, Shen Lucy Q, Pasquale Louis R, Boland Michael V et al.

This study found glaucoma visual field patterns in one eye predict defects in the other, aiding clinicians in interpreting visual field loss and managing uncertainty.

Yousefi Siamak, Elze Tobias, Pasquale Louis R, Saeedi Osamah, Wang Mengyu, Shen Lucy Q et al.

An AI dashboard effectively mapped diverse glaucoma visual field loss patterns, showing 77% sensitivity for progression. This offers clinicians a user-friendly tool to monitor disease severity and progression.

Wang Mengyu, Tichelaar Jorryt, Pasquale Louis R, Shen Lucy Q, Boland Michael V, Wellik Sarah R et al.

AI identified 14 central visual field patterns in end-stage glaucoma. Key finding: initial central loss is often nasal, with one specific nasal pattern prone to total blindness, aiding prognosis and management.

Bommakanti Nikhil, De Moraes Carlos G, Boland Michael V, Myers Jonathan S, Wellik Sarah R, Elze Tobias et al.

Older age and worse baseline vision loss predict faster glaucoma progression, highlighting the need for early detection and aggressive treatment, especially for older patients with existing damage.

Wang Mengyu, Shen Lucy Q, Pasquale Louis R, Boland Michael V, Wellik Sarah R, De Moraes Carlos Gustavo et al.

AI classified central visual field patterns in glaucoma, identifying 17 distinct loss types. This improved prediction of future central VF worsening, offering better prognostic insights for patients.

Saeedi Osamah J, Elze Tobias, D'Acunto Loris, Swamy Ramya, Hegde Vikram, Gupta Surabhi et al.

Six VF progression algorithms showed limited agreement, with discordance linked to initial damage and age, highlighting challenges for clinical use and big-data application.

Wang Mengyu, Shen Lucy Q, Pasquale Louis R, Petrakos Paul, Formica Sydney, Boland Michael V et al.

This AI-based method detects glaucoma progression by analyzing spatial visual field patterns, outperforming traditional methods and offering clinicians specific patterns of visual field loss.

Wang Mengyu, Pasquale Louis R, Shen Lucy Q, Boland Michael V, Wellik Sarah R, De Moraes Carlos Gustavo et al.

This study found specific visual field features predict if glaucoma hemifield test results will revert to normal, improving diagnostic accuracy and potentially reducing misdiagnosis of early glaucoma.

Tzu Jonathan H, Shah Christopher T, Galor Anat, Junk Anna K, Sastry Ananth, Wellik Sarah R

Combined cataract and glaucoma surgery achieved favorable refractive outcomes (74%), but less predictably than cataract surgery alone, inducing more astigmatism. Older patients had worse outcomes.

Shah Aparna A, Modi Yasha, Thomas Benjamin, Wellik Sarah R, Galor Anat

Brimonidine eye drops can cause allergic reactions mimicking vernal keratoconjunctivitis, highlighting the need to differentiate drug allergy from underlying ocular surface disease for effective treatment.

Anwar Zane, Wellik Sarah R, Galor Anat

Glaucoma eye drops, especially those with BAK, worsen ocular surface disease. Newer preservative-free or BAK-free options show clinical benefit, highlighting the need to consider these alternatives for patient comfort.